Galmed Pharmaceuticals (GLMD) EBIT (QoQ) (2013 - 2020)
Galmed Pharmaceuticals (GLMD) EBIT (QoQ) (2013 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
-22.01% |
| Dec 31, 2019 |
83.56% |
| Mar 31, 2019 |
9.01% |
| Dec 31, 2018 |
530.27% |
| Sep 30, 2018 |
-77.34% |
| Jun 30, 2018 |
1.41% |
| Mar 31, 2018 |
-29.77% |
| Dec 31, 2017 |
27.99% |
| Sep 30, 2017 |
6.11% |
| Jun 30, 2017 |
-17.80% |
| Mar 31, 2017 |
-33.37% |
| Dec 31, 2016 |
28.75% |
| Sep 30, 2016 |
-9.86% |
| Jun 30, 2016 |
2.88% |
| Mar 31, 2016 |
28.02% |
| Dec 30, 2015 |
28.35% |
| Sep 30, 2015 |
-1.27% |
| Jun 30, 2015 |
1.00% |
| Mar 31, 2015 |
26.59% |
| Dec 30, 2014 |
-37.99% |
